Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission
Franz Buchegger, Cristian Antonescu, Claudine Helg, et al.
Bulletin Du Cancer
|
August 27, 2005
Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature
Anne-Claude George, Mahmut Ozsahin, Robert Janzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 9, 2011
Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies
François Lüthi, Nadia Fucina, Nathalie Divorne, et al.
Leukemia & Lymphoma
|
April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study
Giannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Swiss Medical Weekly
|
August 5, 2011
Diagnosis and treatment of follicular lymphoma
Felicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Clinical Nuclear Medicine
|
September 8, 2012
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance
Franz Buchegger, John O Prior, Gilles Allenbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2005
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics
Cristian Antonescu, Angelika Bischof Delaloye, Marek Kosinski, et al.
British Journal of Haematology
|
March 6, 2010
Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
Biju Krishnan, Monica Else, Geir E Tjonnfjord, et al.
Hematological Oncology
|
September 29, 2016
Y<sup>90</sup> -Ibritumomab tiuxetan (Y<sup>90</sup> -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)
Michèle Voegeli, Stephanie Rondeau, Simona Berardi Vilei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2002
Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study
Abderrahim Zouhair, Damien Weber, Yazid Belkacémi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2011
Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission
Franz Buchegger, Cristian Antonescu, Claudine Helg, et al.
Bulletin Du Cancer
|
August 27, 2005
Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature
Anne-Claude George, Mahmut Ozsahin, Robert Janzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 9, 2011
Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies
François Lüthi, Nadia Fucina, Nathalie Divorne, et al.
Leukemia & Lymphoma
|
April 15, 2003
HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study
Giannicola D'Addario, Alexander Dieterle, Joachim Torhorst, et al.
Swiss Medical Weekly
|
August 5, 2011
Diagnosis and treatment of follicular lymphoma
Felicitas Hitz, Nicolas Ketterer, Andreas Lohri, et al.
Clinical Nuclear Medicine
|
September 8, 2012
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance
Franz Buchegger, John O Prior, Gilles Allenbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2005
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics
Cristian Antonescu, Angelika Bischof Delaloye, Marek Kosinski, et al.
British Journal of Haematology
|
March 6, 2010
Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
Biju Krishnan, Monica Else, Geir E Tjonnfjord, et al.
Hematological Oncology
|
September 29, 2016
Y<sup>90</sup> -Ibritumomab tiuxetan (Y<sup>90</sup> -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05)
Michèle Voegeli, Stephanie Rondeau, Simona Berardi Vilei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 19, 2002
Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study
Abderrahim Zouhair, Damien Weber, Yazid Belkacémi, et al.
Page
of 5